Front Range Laboratories, Incorporated, Loveland, CO

Is Front Range Laboratories, Incorporated registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Front Range Laboratories, Incorporated hold a Colorado pharmacy license?

No license with this exact name and city was found in the Colorado State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed.

Has Front Range Laboratories, Incorporated had a state board action or FDA letter?

FDA letters: no matching record found on FDA’s compounding inspections and actions page (current as of Oct 22, 2026, covering 2019 on) on Nov 15, 2026; the page lists 1 Form 483 (Mar 20, 2020) for Front Range Laboratories, Incorporated. State board actions: no Colorado State Board of Pharmacy action under this exact name and city was found in the board’s license dataset (actions dated Oct 11, 1985 to Oct 30, 2026) on Nov 15, 2026.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Front Range Laboratories, Incorporated
Location
Loveland, CO
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Mar 20, 2020
FDA Data Dashboard inspections
1 inspection: 1 VAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 3 observations
State board records
No exact match

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Front Range Laboratories, Incorporated, a 503A facility, with 1 dated action.

Document
Mar 20, 2020Form 483483 Issued 03/20/2020fda.gov

A Form 483 lists investigator observations, not a final FDA determination.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Front Range Laboratories Inc, Loveland, CO (FEI number 3003240654), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Mar 20, 2020Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30032406541121761

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 3 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Mar 16, 2020 to Mar 20, 2020: 3 observations

Firm on the cover
Front Range Laboratories, Incorporated, 3985 S Lincoln Ave, Loveland, co 80537-2531
FEI number
3003240654
Establishment type on the cover
Testing Laboratory
FDA district office on the cover
6th & Kipling St. (P. 0. Box 25087) Denver, co 80225 -0087
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

The accuracy, specificity and reproducibility of test methods have not been established.

Specifically, the specificity studies for the assay test methods <Redacted B4> "HPLC Analysis for Hydromorphone HCl" and <Redacted B4> "HPLC Analysis for Fentanyl Citrate or Fentanyl Injection" were inadequate in that the chromatographic separation of impurities and active peaks was not determined. The studies did not include the fortification of known impurities to test samples to optimize the separation of each component observed in the chromatograms. <Redacted B4> studies were performed according to document: HPLC-SOP-008, "Drug Product <Redacted B4> Study." The procedure was deficient in that:

A.

< R edacted B4> concentrations were not specified

p B. The exposure times for <Redacted B4> were not provided.

(~ 4) C. The <Redacted B4> study did not follow ICH <Redacted B4> Stability although ICH and USP guidelines were referenced in document no.: <Redacted B4> "Method Selection, Validation and Verification."

hd

The test methods were used to assay Hydrommphone HCl and Fentanyl Citrate drug products.

Observation 2

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and written.

Specifically, airflow visualization (smoke) studies, conducted October 24, 2014, are deficient in determining the effect on unidirectional air flow as they do not include considerations for:

A. The presence of maximum sample load and equipment within the ISO 5 classified laminar flow hood.

B. Effect of operators working within the ISO 5 classified laminar flow hood.

C. Maximum number of operators present within the ISO classified areas.

Observation 3

Input to and output from records or data are not checked for accuracy.

Specifically, a Microsoft Excel spreadsheet was used to calculate assay values from reference standard solution concentrations, sample solution concentrations and chromatographic data. The spreadsheet, "HPLC-F006.6 HPLC Sample Prep and Final Data Template," was also used to evaluate system suitability elements such as injection precision, retention time comparisons and check standard comparison for agreement with acceptance criteria. The document <Redacted B4>, <Redacted B4> of <Redacted B4> ," established a procedure by which <Redacted B4> were defined, administered, controlled and secured. Although the procedure referenced the document <Redacted B4> , "Calculated/Customized Field Validation", neither the procedure nor the referenced document provided instructions for validating spreadsheets. The procedure did not include instructions to challenge the data inputs into the spreadsheet during verification. Additionally, there was no instruction for periodic assessment of the spreadsheet due to software updates or deterioration of software performance. ...

Read the full 483 (PDF on fda.gov)

State board of pharmacy records

No license with this exact name and city was found in the Colorado State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. Board file.

What this covers: Discipline the Department of Regulatory Agencies publishes with each license in the dataset (case number, program action and effective date), worded as the department gives it. Actions in the data are dated Oct 11, 1985 to Oct 30, 2026.

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.